Latest
What the EU MDR’s Expanded Well-Established Technology Scope Means for Manufacturers
Expanded EU MDR Scope for Well-Established Technology (WET) The European Commission’s adoption of Delegated Regulations (EU) 2026/1359 and (EU) 2026/1451 marks an important evolution in the implementation of the Medical Device Regulation (MDR). By expanding the range of medical devices considered to have… Read More
TL Shorts
Insights
The MDR/IVDR Revision: Impact on Clinical Evaluations and Clinical Investigations
Proposed MDR/IVDR revisions aim to reduce regulatory burden but risk weakening the clinical evidence framework that underpins patient safety. Expanding WET pathways, reducing clinical investigations, and limiting oversight could allow devices to reach the market with insufficient evidence and transparency.
By:
Ester Leoni and Richard Holborow,
Global Regulatory Communication Manager | Head of Clinical Compliance
Biocompatibility
Instructions for use
Compatibility
Disinfection